Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ANAPTYSBIO-INC-33634949/news/Anaptys-to-Provide-Overview-of-Rosnilimab-a-PD-1-Agonist-at-Virtual-R-D-Event-on-Wednesday-Oct-2-45019618/?utm_source=whatsapp&utm_medium=social&utm_campaign=share